Ausgabe 7/2020
Inhalt (32 Artikel)
Hematological findings in coronavirus disease 2019: indications of progression of disease
Xiaoqing Liu, Run Zhang, Guangsheng He
Antifungal prophylaxis and novel drugs in acute myeloid leukemia: the midostaurin and posaconazole dilemma
Jannik Stemler, Philipp Koehler, Christian Maurer, Carsten Müller, Oliver A. Cornely
Modern management of splenomegaly in patients with myelofibrosis
Douglas Tremblay, Myron Schwartz, Richard Bakst, Rahul Patel, Thomas Schiano, Marina Kremyanskaya, Ronald Hoffman, John Mascarenhas
Functional polymorphisms of BCL11A and HBS1L-MYB genes affect both fetal hemoglobin level and clinical outcomes in a cohort of children with sickle cell anemia
Rahyssa Rodrigues Sales, André Rolim Belisário, Gabriela Faria, Fabiola Mendes, Marcelo Rizzatti Luizon, Marcos Borato Viana
Fifteen years of newborn sickle cell disease screening in Madrid, Spain: an emerging disease in a European country
Marina García-Morín, Eduardo J. Bardón-Cancho, Cristina Beléndez, Rosario Zamarro, Cristina Béliz-Mendiola, Milagros González-Rivera, Cruz Vecilla, Lucía Llorente-Otones, Vanesa Pérez-Alonso, Sonsoles San Román, Elena Sebastián, Elena Dulín, Elena Cela
Genotypic-phenotypic heterogeneity of δβ-thalassemia and hereditary persistence of fetal hemoglobin (HPFH) in India
Priya Hariharan, Pooja Kishnani, Pratibha Sawant, Manju Gorivale, Pallavi Mehta, Neha Kargutkar, Roshan Colah, Anita Nadkarni
Immunosuppression therapy is effective for both acquired tumor-associated and primary pure red cell aplasia: a match pair case-control study
Zesong Chen, Miao Chen, Chen Yang, Bing Han
Nationwide study of paroxysmal nocturnal hemoglobinuria in South Korea: paradox of eculizumab
Ka-Won Kang, Hyemi Moon, Byung-Hyun Lee, Min Ji Jeon, Eun Sang Yu, Dae Sik Kim, Se Ryeon Lee, Hwa Jung Sung, Chul Won Choi, Byung Soo Kim, Juneyoung Lee, Yong Park
Baseline clinical characteristics and disease burden in patients with paroxysmal nocturnal hemoglobinuria (PNH): updated analysis from the International PNH Registry
Hubert Schrezenmeier, Alexander Röth, David J. Araten, Yuzuru Kanakura, Loree Larratt, Jamile M. Shammo, Amanda Wilson, Gilda Shayan, Jaroslaw P. Maciejewski
Dynamics of hematopoiesis is disrupted by impaired hematopoietic microenvironment in a mouse model of hemophagocytic lymphohistiocytosis
Isao Tsuboi, Tomonori Harada, Yoko Hirabayashi, Shin Aizawa
Renin angiotensin system inhibitors reduce the incidence of arterial thrombotic events in patients with hypertension and chronic myeloid leukemia treated with second- or third-generation tyrosine kinase inhibitors
Olga Mulas, Giovanni Caocci, Fabio Stagno, Massimiliano Bonifacio, Mario Annunziata, Luigiana Luciano, Ester Maria Orlandi, Elisabetta Abruzzese, Nicola Sgherza, Bruno Martino, Francesco Albano, Sara Galimberti, Patrizia Pregno, Monica Bocchia, Fausto Castagnetti, Mario Tiribelli, Gianni Binotto, Antonella Gozzini, Isabella Capodanno, Claudio Fozza, Debora Luzi, Fabio Efficace, Maria Pina Simula, Luigi Scaffidi, Fiorenza De Gregorio, Chiara Elena, Malgorzata Monika Trawinska, Daniele Cattaneo, Imma Attolico, Claudia Baratè, Francesca Pirillo, Anna Sicuranza, Gabriele Gugliotta, Rossella Stella, Emilia Scalzulli, Alessandra Iurlo, Robin Foà, Massimo Breccia, Giorgio La Nasa
LPS-induced expression and release of monocyte tissue factor in patients with haemophilia
Katharina Holstein, Anna Matysiak, Leonora Witt, Bianca Sievers, Lennart Beckmann, Munif Haddad, Thomas Renné, Minna Voigtlaender, Florian Langer
Hematological malignancies in Ukraine in post-Chernobyl era: sources of data and their preliminary analysis
Stella V. Koval, Daniil F. Gluzman, Lilia M. Sklyarenko, Tetiana S. Ivanivska, Mykhailo P. Zavelevich, Alex A. Philchenkov, Nataliia K. Rodionova, Vasyl L. Novak, Zvenislava V. Masliak, Yaroslava I. Vyhovska
Monosomal karyotype and chromosome 17p loss or TP53 mutations in decitabine-treated patients with acute myeloid leukemia
Heiko Becker, Dietmar Pfeifer, Gabriele Ihorst, Milena Pantic, Julius Wehrle, Björn H. Rüter, Lars Bullinger, Björn Hackanson, Ulrich Germing, Andrea Kuendgen, Uwe Platzbecker, Konstanze Döhner, Arnold Ganser, Anne Hagemeijer, Pierre W. Wijermans, Hartmut Döhner, Justus Duyster, Michael Lübbert
A novel NAP1L4/NUTM1 fusion arising from translocation t(11;15)(p15;q12) in a myeloid neoplasm with eosinophilia and rearrangement of PDGFRA highlights an unusual clinical feature and therapeutic reaction
Zhao Cheng, Yunya Luo, Yang Zhang, Yewei Wang, Yi Chen, Yunxiao Xu, Honling Peng, Guangsen Zhang
Lymphopenia at diagnosis predicts survival of patients with immunodeficiency-associated lymphoproliferative disorders
Mizuki Watanabe, Junya Kanda, Masakatsu Hishizawa, Momoko Nishikori, Tadakazu Kondo, Kouhei Yamashita, Akifumi Takaori-Kondo
Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis—a dangerous disease
Zhili Jin, Yini Wang, Na Wei, Zhao Wang
The interval between progression and therapy initiation is the key prognostic parameter in relapsing diffuse large B cell lymphoma: analysis from the Czech Lymphoma Study Group database (NIHIL)
Andrea Janikova, Jozef Michalka, Zbynek Bortlicek, Renata Chloupkova, Vit Campr, Natasa Kopalova, Pavel Klener, Katerina Benesova, Jitka Hamouzova, David Belada, Vit Prochazka, Robert Pytlik, Jan Pirnos, Juraj Duras, Heidi Mocikova, Marek Trneny
Progression of disease within 2 years (POD24) is a clinically relevant endpoint to identify high-risk follicular lymphoma patients in real life
Clara Sortais, Anne Lok, Benoit Tessoulin, Thomas Gastinne, Béatrice Mahé, Viviane Dubruille, Nicolas Blin, Cyrille Touzeau, Anne Moreau, Céline Bossard, Pierre Peterlin, Alice Garnier, Thierry Guillaume, Amandine Le Bourgeois, Patrice Chevallier, Philippe Moreau, Christophe Leux, Steven Le Gouill
R-CHOP appears to be the best first-line treatment for second primary diffuse large B cell lymphoma: a cancer registry study
T. Systchenko, G. Defossez, S. Guidez, C. Laurent, M. Puyade, C. Debiais-delpech, B. Dreyfus, A. Machet, X. Leleu, V. Delwail, P. Ingrand
Improved time to treatment failure and survival in ibrutinib-treated malignancies with a pharmaceutical care program: an observational cohort study
Jeremie Zerbit, Sylvie Chevret, Sophie Bernard, Marie Kroemer, Charlotte Ablard, Stephanie Harel, Pauline Brice, Isabelle Madelaine, Catherine Thieblemont
Results of R-ESHAP as salvage therapy in refractory/relapsed follicular lymphoma: a real-world experience on behalf of GELCAB group
A. Muntañola, T. Baumann, A. C. Caballero, B. Sánchez-González, S. Mercadal, L. Escoda, A. Soler, L. Iserte, M. Canet, M. T. Villalobos, L. Magnano, M. Sorigué, O. García, A. Salar, A. López-Guillermo, J. M. Sancho
Outcome of stem cell transplantation for Waldenström’s macroglobulinemia: analysis of the Japan Society for Hematopoietic Cell Transplantation (JSHCT) Lymphoma Working Group
Masatoshi Sakurai, Takehiko Mori, Hitoji Uchiyama, Hiroatsu Ago, Koji Iwato, Tetsuya Eto, Hiromi Iwasaki, Takahito Kawata, Hiroyuki Takamatsu, Satoshi Yamasaki, Minoko Takanashi, Tatsuo Ichinohe, Yoshiko Atsuta, Ritsuro Suzuki
Comparison of central nervous system relapse outcomes following haploidentical vs identical-sibling transplant for acute lymphoblastic leukemia
Qi Chen, Xin Zhao, Hai-xia Fu, Yu-hong Chen, Yuan-yuan Zhang, Jing-zhi Wang, Yu Wang, Chen-hua Yan, Feng-rong Wang, Xiao-dong Mo, Wei Han, Huan Chen, Ying-jun Chang, Lan-ping Xu, Kai-yan Liu, Xiao-jun Huang, Xiao-hui Zhang
Geriatric nutritional risk index as a useful prognostic factor in second allogeneic hematopoietic stem cell transplantation
Satoshi Kaito, Atsushi Wada, Hiroto Adachi, Ryosuke Konuma, Yuya Kishida, Akihito Nagata, Tatsuya Konishi, Yuta Yamada, Takuma Kumagai, Kota Yoshifuji, Junichi Mukae, Megumi Akiyama, Kyoko Inamoto, Takashi Toya, Aiko Igarashi, Yuho Najima, Hideharu Muto, Takeshi Kobayashi, Kazuhiko Kakihana, Kazuteru Ohashi, Hisashi Sakamaki, Noriko Doki
Safe administration of granulocyte colony-stimulating factor (G-CSF) to a patient with G-CSF–producing multiple myeloma
Taku Kikuchi, Jun Kato, Yuya Koda, Masatoshi Sakurai, Yuichiro Hayashi, Takehiko Mori
Acquired amegakaryocytic thrombocytopenic purpura possibly induced by anti-PD-1 antibody
Satoshi Iyama, K. Takada, M. Yoshida, D. Takahashi, M. Kobune
Uterine myeloid sarcoma
Giovanni Martino, Magda Zanelli, Maurizio Zizzo, Martina Quintini, Linda Ricci, Andrea Marra, Stefano Ascani
Autoimmune thrombotic thrombocytopenic purpura (TTP) associated with COVID-19
Nil Albiol, Rahinatu Awol, Rodrigo Martino
Could ruxolitinib be effective in patients with COVID-19 infection at risk of acute respiratory distress syndrome (ARDS)?
Giovanni Caocci, Giorgio La Nasa
SARS-CoV-2 impact in a community-based hematological ward in an Italian Red Zone
Giuseppe Visani, Martina Chiarucci, Barbara Guiducci, Maria Capalbo, Alessandro Isidori
COVID-19 infection associated with autoimmune hemolytic anemia
Antoine Capes, Sarah Bailly, Philippe Hantson, Ludovic Gerard, Pierre-François Laterre